chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Appendectomy; This spontaneous case was reported by an other health care professional and describes the occurrence of APPENDICECTOMY (Appendectomy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced APPENDICECTOMY (Appendectomy) (seriousness criterion hospitalization). In March 2021, APPENDICECTOMY (Appendectomy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient took first 2 doses back in Jan/Feb and ended up with an appendectomy a month later.  Treatment information was not provided.  Company comment: This is a spontaneous case concerning a patient of an unknown age and gender  with no medical history reported, who experienced serious, unexpected event of appendicectomy. The event occurred approximately 1 month after the administration of second dose of mRNA-1273 vaccine. Clinical course was not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-450490 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a patient of an unknown age and gender  with no medical history reported, who experienced serious, unexpected event of appendicectomy. The event occurred approximately 1 month after the administration of second dose of mRNA-1273 vaccine. Clinical course was not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Patient received intramuscular flu shot injection on 11/2/14. She states she was in a lot of pain for about three weeks went to see her doctor. He said that hit a nerve and that is why it is still hurting. She has  since been prescribed pain pills, muscle relaxers, cortisone injection which none of them have helped. Doctor is now prescribing physical therapy for her arm.
There's little swelling around site on one arm.  But,  she suddenly became itchy,  uncomfortable all over with no visible skin rash
syncope;diaphoretic;sweaty Narrative: Approximately 15 minutes after 1st COVID vaccine dose patient got up to walk out the door and collapsed. He was found to be sweaty and diaphoretic with syncopal episode. After a hour of observation, patient began to feel better and was able to go home.
This spontaneous report was received from a consumer referring herself as currently non-pregnant adult female patient of unknown age. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, reported as when she was an infant, the patient was vaccinated with a shot of unspecified chicken pox vaccine (manufacturer unknown) (dose, units and frequency not reported) (lot# and expiration date unknown). On an unknown date, the patient developed chicken pox when she was in fourth grade. As an adult, she experienced shingles three times. Patient wanted to have children, so her physician recommended to get vaccine live VARIVAX, then wait for few months before planning for pregnancy. The patient was recovered from the events. The causal assessment was not provided.
My second shot was 4/21. At midnight I woke up puking and continued to puke throughout the night. Had a terrible migraine after second shot. I used to suffer of migraines, but have not had them since I was 36. Today I still get little nausea and migraine aura that doesn?t last more than five minutes. But I think the vaccine created this. I certainly hope it goes away. Another thing i have noted is that some days i get again for no more than five minutes an itch on the site where they gave me the shot. Need to know why it is still going on and most importantly will it go away. Sometimes that little migraine aura wakes me up too early in the morning. My lower back is hurting still. Please advise. Thanks
This spontaneous report as received from a licensed practical nurse, who reported that on 13-AUG-2013, one patient of unknown age and gender received one dose of GARDASIL (lot # reported as J004197, expiration date 27-NOV-2015) (dose and route were not reported) exposed to 31F for 84 hours over the past two months, since approximately June 2013. Concomitant medications were not reported. No adverse effects reported. This case is linked to cases 1308USA010552, 1309USA004737, 1309USA004745, 1309USA004747 via same reported link. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 70 year old female patient with drug reaction of oxycodone (nausea and vomiting), penicillin (skin rash) and codeine (made her crazy). The patient did not have any pertinent medical history. On 14-MAR-2013 the patient was vaccinated with PNEUMOVAX23 (lot # H014653, expiration date was 19-APR-2014, 0.5 ml, subcutaneous) as part of vaccine protocol while hospitalized for hip or knee surgery. Concomitant therapies included atenolol, CELECOXIB, dicyclomine hydrochloride, "ducosate sodium", enoxaparin sodium, ferrous sulfate, levothyroxine sodium, omeprazole, oxycodone, MIRALAX, venlafaxine hydrochloride, TYLENOL, aluminum hydroxide, magnesium hydroxide, MAALOX, bisacodyl, diphenhydramine hydrochloride, acetaminophen, LORTAB, morphine, ZOFRAN, AMBIEN and ropivacaine. On 14-MAR-2012, the patient had developed redness, swelling, tenderness in the arm at injection site. The outcome of events was unknown. Pharmacist stated patient being discharged from hospital 15-MAR-2013. No lab diagnosis studies performed. No treatment was given for adverse events. The relationship between events and PNEUMOVAX23 was unknown. The pharmacist was requesting a lot check for PNEUMOVAX23 lot H014653 (Expired date 19-APR-2014). This is one of several reports received from the same source. Additional information has been requested.
took shot in my grandson did to still got flu in still sick 17 days its been; Initial information was received on 27-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a non-health-care professional.  This case involves an unknown age male patient who had an event, "took shot in my grandson did to still got flu in still sick 17 days its been" after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation).      On an unknown date the patient had a non-serious event of took shot in my grandson did to still got flu in still sick 17 days its been (influenza) (unknown latency) following the administration of influenza vaccine.  No lab data was reported.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment.  Outcome: Unknown.
sinusitis; very congested; face, nose, eyes and head hurt a lot; swelling on her forehead and on the head and neck; ears are plugged and unplugged; Could not bear to have her pillow touch her head/back of neck; This spontaneous case was reported by a physician and describes the occurrence of SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck) and EAR DISCOMFORT (ears are plugged and unplugged) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN and OMEPRAZOLE for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 in response to the event was not applicable. Treatment: Antibiotics, nasal spray and Tylenol for the symptoms.   This case was linked to MOD-2021-036905 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: the follow-up were received on 24-MAY-2021 and contain no new information On 24-May-2021: Translated email added
DATE OF ADMISSION:  01/13/2023 DATE OF DISCHARGE:  01/19/2023 COVID positive date: 1/13/2023 HOSPITAL COURSE The patient is an 84-year-old female with past medical history significant for CLL, atrial fibrillation, hypertension, hyperlipidemia, anxiety, and recent pleural effusion and pneumonia.  The patient was admitted in December for pneumonia and treated with Zithromax and Ceftin with treatment through 01/05/2023.  She was discharged to subacute rehab where she resided until readmission.  She started eating less and feeling weak the previous weekend and developed cough.  She also developed low-grade fever on Monday.  She tested positive for COVID on Monday, 01/08/2023.  She has been afebrile since that time.  She has no history of COVID and is fully vaccinated.  She was hypoxic per EMS, 85% on evaluation.  She was given 2 L per nasal cannula, improved, but was again hypoxic at 80% in the ER.  Chest x-ray showed only tiny pleural effusion, moderate interstitial edema, pneumonitis.  Recent left upper lobe pneumonia appeared resolved.  She was admitted for respiratory failure and hypoxia.    The patient was admitted and started on remdesivir and dexamethasone for her COVID-19.  Pulmonology was consulted and followed for her thoracostomy tube that was placed by Dr. in December.  They recommended holding drainage for a week and attempting draining on 01/17.  If no output, they could pull the drain.  Her drain was removed during hospitalization on 01/18/2023.  The patient received electrolyte replacement during hospitalization as needed.  Per Dr. plan was to hold ibrutinib for another 4 weeks and reconsider based on clinical course of the patient.  The patient had repeat echocardiogram on 01/14/2023 that showed ejection fraction of 71% with small pericardial effusion without evidence of tamponade.  As patient was stable, plans were made to discharge the patient to subacute rehab.  She was discharged to a different facility than she was at previously as she was unhappy with the care there.   CONDITION ON DISCHARGE Stable.
5JUN97 1yr well child visit;16JUn rash x 2 days over entire body, fever;no change in diet, measles like rash;
experiencing a runny nose; This is a spontaneous report from a contactable consumer (patient) communicated via Pfizer-sponsored program. A female patient of unspecified age received bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot number: not provided, expiration date not provided), via unknown route of administration, administered on an unknown date, as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication was not provided. On an unknown date the patient experienced a runny nose. The patient wanted to confirm if she should take the second dose while experiencing a runny nose. Outcome of event was unknown.  Follow-up attempts completed. No further information expected.
Bells Palsy; This is a spontaneous report from a Pfizer sponsored program. A contactable other HCP (patient daughter) reported for a male patient (reporter father). A male patient of an unspecified age received bnt162b2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced bells palsy on an unspecified date. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on the limited  information in the case report, a possible causal relationship between the event Bell's palsy and suspect drug BNT162B2 cannot be excluded The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
ESRD patient, developed dyspnea, fatigue, pulmonary edema after getting 2nd vaccine requiring hospitalization, BiPAP, dialysis
Blood sugar was elevated in the evening after receiving injection. Patient newly diagnosed diabetic, insulin dependant. Blood sugars remain elevated as of 12/7/09 but are slowly coming back down. Had headache also, but is slightly better than after started.
Hands feel swollen; Itching at the injection site; Red patch at the injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Hands feel swollen), VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Red patch at the injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Red patch at the injection site). On 13-Jan-2021, the patient experienced PERIPHERAL SWELLING (Hands feel swollen). At the time of the report, PERIPHERAL SWELLING (Hands feel swollen) had not resolved and VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Red patch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Left thumb warts (unspecified type of warts) resolved; Hpv vaccine used fro left thumb warts (unspecified type of warts); This literature marketed report has been received from the authors of the published article, concerning a 37 year old male patient. The patient's pertinent medical history including therapy with liquid nitrogen, candida albicans, duct tape and curettage. The patient's current conditions and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown) for left thumb warts (unspecified type of warts) (product use in unapproved indication) (strength, dose, frequency, route of administration, lot number and expiration date were not reported).   On an unspecified date, left thumb warts (unspecified type of warts) resolved (drug effective for unapproved indication).   The outcome of drug effective for unapproved indication was unknown.   The causal relationship between the vaccination with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown) and drug effective for unapproved indication was considered as related, as the authors hypothesize that effectiveness of the vaccination with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown) in extragenital warts was due to the cross-protection of extragenital strains.   This is one of several reports received from the same literature.  Sender's Comments:  US-009507513-1912USA001729:
pt states he started feeling pain in the left arm about one hour after the vax.  He had a little back pain that night but could not get out of bed the next morning.  He said it feels like the pain is all over his lower back and in the kidneys.   Pt will contact his PCP.
This spontaneous report as received from a medical assistant refers to a 13 year old female patient with painful menstruations and familial risk (history of aluminum and nickel allergy). On 19-NOV-2014, the patient was vaccinated with a first dose of GARDASIL, .5 ml intramuscular in the left arm, Lot # K009202 and expiration date on 17-DEC-2016. Reporter also mentioned that the patient was prescribed MICROGESTIN on 19-NOV-2014, however the patient had discontinued it (unspecified reason). It was reported that one day and a half after vaccine administration, approximately on 20-NOV-2014, the patient developed a headache and shortness of breath. The patient also developed a numbness of her hands and ankles. The patient went to the emergency room where patient had multiple tests (chest and lung x-ray) and all results were negative. The patient stated that she was had never been tested for allergies so it was not known if the patient was allergic to aluminum and nickel. The patient sought medical attention at emergency room. At the time of the report, the patient had not recovered from the events. The relatedness between the event and suspect therapy was not provided. This is one of several reports received from the same source. Additional information has been requested.
When woke up felt sore, tired, lethargic, slight headache. While driving to work neoticed felt alternating cold and hot and realized might have a fever. All day felt rundown, little appetite. By that evening (24 hours after vaccine) took temperature and had a slight fever 99 degrees and then every half hour was going up approximate half a degree until about 7 p.m. I took ibuprofen when fever reached 101.4. Felt like I could barely move and went to sleep. Fever gone in a.m. and felt progressively better throughout nexy day although took ibuprofen for headache during work.
Severe debilitating neck, shoulder, arm and finger pain. Patient could not find a comfortable position to lie in. Patient took Ibuprofen and symptoms subsided by morning.
Patient was due for a second dose of the Moderna Covid-19 vaccine but incorrectly received a dose of the Pfizer Covid-19 vaccine.
severe vomiting, diahrea, hallucinations, screaming, swelling of the brain, perforated ear drums, blood in ears, headache, weakness, heart palpations, dizziness, eyes sensitive to light, encephilitis, chills,severe shaking started approximately six hours after vaccine and some symptoms still continuing. 11/26/07-records received for DOS 10/26-10/28/07-DC DX: acute coronary syndrome, myocardial infarction ruled out. Presented to ED with 1-2 day HX of intermittent chest pain radiating to her neck and left arm. Diaphoretic, slightly short of breath.
Patient had an itchy rash about 4 inches in diameter. Instructed to take Benadryl and use topical steroid (triamcinolone is what he had at home.)
I contracted COVID 19 12/4/21 with symptoms of severe headache, shortness of breath, chest pain/tightness, cough, sore throat, muted senses of taste and smell, low grade temp, and fatigue for 7 days before symptoms began to resolve.
Dizziness, Fever, NauseaVomiting, chills, body aches (unspecified) Narrative:  Other Relevant History:
Headache, fatigue, body aches, nausea, vomiting  Started Monday, January 11, 2021around 3:45pm
A nurse reported that a 43 year old female received TD Adsorbed, Ultrafined on 1/24/00. She returned to the physician's office on 1/27/00, after she developed a 3cm to 4cm area of redness and warmth at the injection site. She was treated with hydrocortisone cream. This is 1 of 3 pts from this facility who developed an injection site reaction following receipt of either Tetanus Toxoid Adsorbed or Diphtheria and Tetanus Toxoid Adsorbed.
The patient developed swelling at the injection site immediately after the injection. It was about a 1 inch swelling. Per the patient, it was not painful. We gave the patient an ice pack to put on the area and told him to take some benadryl when he got home. We monitored him for 15 minutes after which he left. We called him back after a few hours and he said the swelling went down a bit but was now bruised. Other than that, he did not have any concerns. We asked him to keep an eye on it and give us a call back if he had any concerns.
Pt had a near syncopal episode. With hypotension post vaccinate. Recovered after 30 min went to the ER to get checked out
Night after shot was administered I woke up feeling really nauseous and starting projectile vomiting all night. The next day I had a fever, chills and body pain all over, in addition to nausea and extreme lethargy/sleepiness. The puking has stopped and chills went away after two days, but the nausea, extreme lethargy and mind fog has continued on for several more days and hasn't gotten better.
a little arm soreness; This is a spontaneous report from a contactable consumer (patient). This female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number /expiration date: unknown), via unknown route of administration, on 19Jan2021 as a single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown.  On Jan2021, the patient reported that she took the 1st vaccine yesterday.  She did not have any problems other than a little arm soreness. The outcome of the event was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
9 days following administration of vaccines child developed purpura / vasculitis on lower extremities. Purpura / vasculitis came and went for a total of 12.5 weeks. Child had no other symptoms during the 12.5 weeks. Blood work was conducted 3 weeks following onset of purpura/ vasculitis, found above normal platelet levels. Purpura / vasculitis self resolved after 12.5 weeks with no intervention.  Urinary analysis was conducted 6 months after purpura /vasculitis resolved. Urinary analysis was normal and showed no renal involvement.
pt recv vax & 2 days later devel inj site rxn characterized by a 2-inch circle of redness & a 1.5 inch area which was solid, white & raised;pt recovered as of the date of this report;this is one to tow children from this site to exp rxn;